Comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation using network meta-analysis

被引：0
|
作者：
Marx, Svetlana [1 ]
Harenberg, Job [1 ]
Wehling, Martin [1 ]
Weiss, Christel [2 ]
Diener, Hans-Christoph [3 ]
Marder, Victor J. [4 ]
Lip, Gregory Y. H. [5 ]
机构：
[1] Fac Med Mannheim, Dept Clin Pharmacol, D-68167 Mannheim, Germany
[2] Fac Med Mannheim, Dept Biometry & Stat, D-68167 Mannheim, Germany
[3] Univ Essen Gesamthsch, Dept Neurol, Essen, Germany
[4] UCLA Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[5] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England
来源：
THROMBOSIS RESEARCH | 2012年 / 130卷
关键词：
D O I：
10.1016/j.thromres.2012.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S100 / S101
页数：2
相关论文
共 50 条
  • [21] Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
    Miller, Corey S.
    Grandi, Sonia M.
    Shimony, Avi
    Filion, Kristian B.
    Eisenberg, Mark J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (03): : 453 - 460
  • [22] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Among Non-Valvular Atrial Fibrillation Patients: A Propensity Score Matched Analysis of Four Large Databases
    Deitelzweig, Steve
    Keshishian, Allison
    Li, Xiaoyan
    Hamilton, Melissa
    Masseria, Cristina
    Gupta, Kiran
    Luo, Xuemei
    Mardekian, Jack
    Friend, Keith
    Nadkarni, Anagha
    Pan, Xianying
    Lip, Gregory Y.
    [J]. CIRCULATION, 2017, 136
  • [23] Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients
    Lip, Gregory Y.
    Lanitis, Tereza
    Kongnakorn, Thitima
    Phatak, Hemant
    Liu, Larry Z.
    Lawrence, John
    Dorian, Paul
    [J]. CIRCULATION, 2014, 130
  • [24] Effectiveness and safety of apixaban, dabigatran and warfarin compared to rivaroxaban in non-valvular atrial fibrillation; a Norwegian nationwide cohort study
    Rutherford, O. -C. W.
    Jonasson, C. J.
    Ghanima, W. G.
    Halvorsen, S. H.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1846 - 1846
  • [25] Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study
    Kjerpeseth, Lars J.
    Selmer, Randi
    Ariansen, Inger
    Karlstad, Oystein
    Ellekjaer, Hanne
    Skovlund, Eva
    [J]. PLOS ONE, 2019, 14 (08):
  • [26] The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
    Shimokawa, Hiroaki
    Yamashita, Takeshi
    Uchiyama, Shinichiro
    Kitazono, Takanari
    Shimizu, Wataru
    Ikeda, Takanori
    Kamouchi, Masahiro
    Kaikita, Koichi
    Fukuda, Koji
    Origasa, Hideki
    Sakuma, Ichiro
    Saku, Keijiro
    Okumura, Yasuo
    Nakamura, Yuichiro
    Morimoto, Hideo
    Matsumoto, Naoki
    Tsuchida, Akihito
    Ako, Junya
    Sugishita, Nobuyoshi
    Shimizu, Shogo
    Atarashi, Hirotsugu
    Inoue, Hiroshi
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 258 : 126 - 132
  • [27] Comparison of dabigatran and warfarin used in patients with non-valvular atrial fibrillation Meta-analysis of random control trial
    Yu, Yi-bo
    Liu, Jing
    Fu, Guo-hua
    Fang, Ren-yuan
    Gao, Fang
    Chu, Hui-min
    [J]. MEDICINE, 2018, 97 (46)
  • [28] PHARMACOECONOMIC ANALYSIS OF DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION: COMPARISON WITH RIVAROXABAN OR APIXABAN
    Gay-Molina, J. G.
    Herran, S.
    Sorensen, S.
    Gonschior, A. K.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A115 - A115
  • [29] EFFICACY AND SAFETY OF RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION IN PATIENTS WITH SEVERE RENAL IMPAIRMENT
    Ali, S.
    Wakefield, L. A.
    Saja, K.
    [J]. HAEMATOLOGICA, 2016, 101 : 140 - 140
  • [30] Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
    Skjoth, Flemming
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2014, 111 (05) : 981 - 988
12345